期刊文献+

PAPP-A水平及IVS6+95多态性在预测PCI术后再狭窄的价值 被引量:3

The Value of Pregnancy Associated Plasma Protein A and IVS6+95 Gene Polymorphism in Prediction of Restenosis after Percutaneous Coronary Intervention
下载PDF
导出
摘要 对超敏C反应蛋白(hs-CRP)、妊娠相关蛋白A(PAPP-A)及IVS6+95(C/G)基因多态性预测不稳定型心绞痛(UAP)患者经皮冠状动脉成形术(PCI)术后再狭窄的意义进行探讨。UAP患者行PCI术(TIMI血流达到3级),3个月~9个月复查冠脉造影,选取血管腔内径狭窄≥75%者(再狭窄组)86例、无再狭窄组(对照组)152例,测定术前术后24hPAPP-A、hs-CRP水平。采用基因测序法分析IVS6+95多态性。再狭窄组术后血清PAPP-A、hs-CRP水平较本组术前明显增高(P<0.001)。对照组术后血清PAPP-A、hs-CRP水平较本组术前明显下降(P<0.001)。再狭窄组IVS6+95中CC基因频率明显高于未发生组(P<0.05),而等位基因C频率无明显差异。PCI术后PAPP-A、hs-CRP血清水平可作为预测冠脉再狭窄的指标,IVS6+95(C/G)多态性可能与术后再狭窄有关,其中基因型CC是致病的基础。 Abstract:To explore the value of pregnancy associated plasma protein A, high sensitivity C--reactive protein and IVS6 + 95 gene polymorphism in prediction of restenosis after percutaneous coronary intervention. The patients with unstable angina pectoris were performed PC1. Those patients were classified as group A (86 cases with related coronary artery lumen loss more than 75% in diameter 3-9months after PCI) and group B(the rest 152 cases with related coronary lumen loss less than 75%). Serum PAPP-A and hs-CRP levels were examined before and 24h after coronary angiography. The gene polymorphisms was analyzed by gene sequencing. Serum PAPP-A and hs-CRP levels were significantly increased In group A and decreased in group B after PCI (P〈0. 001). The CC gene frequency of PAPP-A gene IVS6+95 was signifi- cantly higher in group A than in group B (P〈0.05). But there were no difference in the frequency of allele C between two groups (P〉0.05). PAPP- A and hs- CRP level increase after PCI have a strong power in prediction of coronary artery restenosis after PCI. The polymorphism of PAPP-A gene IVS6+95(C/G) may be associated with postoperative resteno- sis and CC genotypes may he the foundation of pathogen.
出处 《医学与哲学(B)》 2013年第1期26-28,69,共4页 Medicine & Philosophy(B)
基金 山东省科技攻关项目 项目编号:2008GG30002018
关键词 超敏C反应蛋白 妊娠相关蛋白A 基因多态性 经皮冠状动脉成形术 再狭窄 high sensitivity C-reactive protein, pregnancy associated plasma protein A, gene polymorphism, percutaneouscoronary intervention, coronary restenosis
  • 相关文献

参考文献19

  • 1ConoverCA, Harrington S C, Bale I. K. Differential regulation of pregnancy associated plasma protein: A in human coronary artery endothelial cells and smooth muscle cells[J].wth Horm IGF Res,2008,18(3) :213 -20.
  • 2MasonEJ, MasonEJ, GrellJ A, et al. Insulin likegrowth factor (IGF):I and IGF:II contribute differentially to the phenotype o{ pregnancy associated plasma protein- A knock- out mice [J]rowth rm IGF Res,2011,21(5):243-247.
  • 3Li X P, Zhou S H,Tang j J,et al. Association between plasma preg nancy:associated plasma protein a and restenosis after percutanc ous coronary angioplasty[J].rc J, 2008,72 (5) : 729- 733.
  • 4Yasuda S, Yasuda S, Miyazaki tion of matrix metallroteinase S, et al. Enhanced cardiac produc 2 and :9 and its attenuation as sociated with pravastatin treatment in patients with acute myocard al infarction[J]. Clin Sci (Lond), 2007,112 ( 1 ) : 43-49.
  • 5Park S, Youn J C, Shin D J, et al. Genetic polymorphism in the pregnancy associated plasma protein: A associated with acute my ocardial infarction[J]. Coron Artery Dis,2007,18(6):417-22.
  • 6唐毅,李江,罗俊.内皮祖细胞治疗对经皮冠脉支架植入术后再内皮化研究进展[J].医学与哲学(B),2012,33(4):35-38. 被引量:1
  • 7Bayes:Genis A, Conover C A, Overgaard M T, et al. Pregnancy:as sociated plasma protein A as a marker of acute coronary syndromes[J]. N EnglJ Med,2001,345(14):1022-1029.
  • 8Iversen K K, Teisner B, Winkel P, et al. Pregnancy associated plasma prmein:A as a marker for myocardial infarction and death in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial[J].Atherosclerosis,2011,214(1):203-208.
  • 9Nesto R. C:reactlve protein, its role in inflammation, Type 2 dia betes and cardiovascular disease, and the effects of insulin sensiti zing treatment with thiazolidinediones[J]. Diabet Med, 2004,21 (8) 810-817.
  • 10Verma S, Kuliszewski M A, Li S H, et al. C:reactive protein at tenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C:reactive Circulation, 2004, 109 ( 17 ) : 2058-2067.

二级参考文献63

  • 1Vaccarino V, Krumholz HM. Risk factors for cardiovascular disease : one down, many more to evaluate. Ann Intern Med, 1999, 131:62-63.
  • 2Puddu PE, Lanti M, Menotti A, et al. Serum uric acid for short 2 term prediction of cardiovascular disease incidence in the Gubbio population Study. Acta Cardiol, 2001,56:243-251.
  • 3Waddington C. Elevated uric acid can raise risk for CHD. Cardiol Today, 1999,2 : 15.
  • 4Beevers DG,Lip G. Is uric acid really an independ cardiovascular risk factor? Lancet, 1998, 352:1556.
  • 5Bickel C, Rupprechet HI, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol, 2002, 89: 12-17.
  • 6Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: the framingham heart study. Ann Intern Med,1999, 131:7-13.
  • 7Alderman MH. Serum uric acid and cardiovascular disease risk. Ann Intem Med, 2000,132:591.
  • 8Fuster V, Badimon BJJ. The pathogenesis of coronary artry dis2 ease and the acute coronary syndromes. N Engl J Med, 1992, 26 : 310-321.
  • 9Freedman DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol, 1995,141:637-644.
  • 10Leyva F,Anlcer S, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J, 1997,18 : 858-865.

共引文献26

同被引文献35

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部